E

Element Biosciences

Low-cost next-generation DNA sequencing technology

Director of Regulatory Affairs

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeSan Diego, CA, USA

About the Job

Requirements

  • A minimum bachelor's degree in life sciences, engineering, regulatory affairs, or a related discipline is required.
  • Typically, 12 or more years of progressively responsible medical device or in vitro diagnostic Regulatory Affairs experience, including substantial responsibility for regulated in vitro diagnostic product development, market authorization, and lifecycle management.
  • Demonstrated experience establishing regulatory strategy for complex diagnostic instruments, in vitro diagnostics, molecular diagnostics, or similarly complex regulated products.
  • Experience leading regulatory programs across multiple major jurisdictions, including experience with the U.S. Food and Drug Administration and/or European Union In Vitro Diagnostic Regulation.
  • Demonstrated ability to advise senior executives and influence product, technical, clinical, quality, and commercial decisions without relying on positional authority.
  • Experience building or scaling a Regulatory Affairs function, team, operating model, or infrastructure.
  • Deep working knowledge of ISO 13485, ISO 14971, post-market requirements, labeling, change control, and applicable medical device/in vitro diagnostic regulatory frameworks.
  • Ability to lift up to 20 pounds.
  • Willingness to travel up to approximately 10% of the time.

Responsibilities

  • Own and lead global regulatory strategy for in vitro diagnostic, next-generation sequencing, software, and regulated life science instrumentation products throughout development, commercialization, and lifecycle management.
  • Serve as the senior Regulatory Affairs advisor to executive leadership and cross-functional teams, providing recommendations on regulatory pathways, risks, tradeoffs, and business implications.
  • Establish regulatory strategies early in product development, including intended use, claims, classification, market pathways, evidence requirements, product configuration, and research-use-only-to-diagnostic considerations.
  • Lead regulatory strategy and execution for global market authorizations, including the United States, European Union, and other priority international markets.
  • Lead significant interactions with regulatory authorities, notified or assessment bodies, authorized representatives, and other external regulatory stakeholders.
  • Establish regulatory strategy and responsibilities for diagnostic partnerships, co-development programs, and other collaborations involving shared or dependent product configurations.
  • Own regulatory assessment and governance for product, software, manufacturing, supplier, labeling, and other lifecycle changes affecting marketed products.
  • Provide regulatory leadership for post-market reporting obligations, including vigilance, adverse event and incident reporting, field actions, and emerging regulatory risks.
  • Establish regulatory governance, decision-making, and escalation mechanisms that enable timely, consistent, and well-documented regulatory decisions.
  • Build and scale the Regulatory Affairs function, including people, external resources, governance, processes, systems, regulatory intelligence, and global registration infrastructure.
  • Represent Regulatory Affairs in product development, portfolio, commercialization, and other enterprise decision-making forums.

Desired Qualifications

  • An advanced degree or Regulatory Affairs Certification is preferred.
  • Experience with both the U.S. Food and Drug Administration and European Union In Vitro Diagnostic Regulation is strongly preferred.

About the Company

Element Biosciences

Low-cost next-generation DNA sequencing technology

Element Biosciences offers the AVITI System, a compact benchtop sequencing platform that provides high-accuracy DNA sequencing at a low cost. The system delivers sequencing data on a small instrument and can be integrated into workflows through partners like QIAGEN, enabling complete NGS solutions. It differentiates itself with a low per-read price of $1 per million reads, strong ecosystem partnerships, and initiatives like the AVITI for All Grant that funds free sequencing. Its goal is to make DNA sequencing more affordable and accessible for academic and industry customers, helping more projects fit within tighter budgets.

Company size
201-500
Company stage
Series E
Total funding
$853M
Headquarters
San Diego, CA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Element Biosciences

See more jobs